Nature

Hodgkin lymphoma

Hodgkin lymphoma is a type of lymphoma (a cancer originating from white blood cells called lymphocytes) characterised by the presence of a type of cell called the ReedSternberg cell. Symptoms include enlargement of lymph nodes, spleen or other immune tissue.

Latest Research and Reviews

Research | 14 October 2022

Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP
- Julia Driessen
- , Marie José Kersten
- & Arjan Diepstra
Leukemia 36, 2853-2862
Research
27 June 2022 | Open Access

Tyramide-conjugated DNA barcodes enable signal amplification for multiparametric CODEX imaging

Tyramide-conjugated DNA barcodes can be used to perform CODEX imaging without modifying primary antibodies and could complement existing CODEX workflows for multiplexed imaging.
- Paul D. Simonson
- , Itzel Valencia
- & Sanjay S. Patel
Communications Biology 5, 627
Research
21 June 2022 | Open Access

The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity
- Shangkun Zhang
- , Chaojiang Gu
- & Tongcun Zhang
Scientific Reports 12, 10488
Research | 12 April 2022

The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
- Ali Bazarbachi
- , Ariane Boumendil
- & Anna Sureda
Leukemia 36, 1646-1653
Research
16 February 2022 | Open Access

3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma
- Aresu Sadeghi Shoreh Deli
- , Sonja Scharf
- & Sylvia Hartmann
Modern Pathology 35, 1431-1438
Research
28 January 2022 | Open Access

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
- Rebecca L. King
- , Alia Gupta
- & Sameer A. Parikh
Blood Cancer Journal 12, 18

All Research & Reviews

News and Comment

Research Highlights | 22 November 2022

Brentuximab vedotin improves outcomes
- Peter Sidaway
Nature Reviews Clinical Oncology 20, 2
Correspondence
05 July 2022 | Open Access

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
- Theodoros P. Vassilakopoulos
- , Evrydiki Kravvariti
- & Gerassimos A. Pangalis
Blood Cancer Journal 12, 102
Correspondence | 29 November 2021

Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients
- Christianne Tolêdo de Souza Leal
- , Luciano José Megale Costa
- & Abrahão Elias Hallack Neto
Bone Marrow Transplantation 57, 309-311
Correspondence | 09 June 2021

Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas
- Francesca Bonifazi
- , Irene Defrancesco
- & Mario Arpinati
Bone Marrow Transplantation 56, 2295-2298
Correspondence
11 May 2021 | Open Access

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
- Hidde L. A. Posthuma
- , Josée M. Zijlstra
- & Avinash G. Dinmohamed
Blood Cancer Journal 11, 87
Research Highlights | 04 August 2020

CAR T cells are active in Hodgkin lymphoma
- David Killock
Nature Reviews Clinical Oncology 17, 592

All News & Comment

Search

Advanced search

Quick links